Kanacef M.C. Intramammary Suspension
Kanacef M.C. Intramammary Suspension
Authorised
This information is not available for this product.
Product identification
Medicine name:
Kanacef M.C. Intramammary Suspension
Active substance:
This information is not available for this product.
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle
-
Meat and offal7day
-
Milk108hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Historical pack size: A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap). 10 tubes per carton.
- A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap). 10 tubes per carton.
- A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap).20 tubes per carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Interchem (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchem (Ireland) Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10555/001/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
